LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 307 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $316,000 | +4.3% | 3,175 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $303,000 | -79.7% | 3,175 | -76.2% | 0.00% | -81.0% |
Q2 2020 | $1,495,000 | +53.8% | 13,365 | 0.0% | 0.02% | +40.0% |
Q1 2020 | $972,000 | -30.2% | 13,365 | +0.6% | 0.02% | +7.1% |
Q4 2019 | $1,392,000 | +4.4% | 13,290 | -0.7% | 0.01% | -6.7% |
Q3 2019 | $1,333,000 | -12.8% | 13,390 | 0.0% | 0.02% | -6.2% |
Q2 2019 | $1,529,000 | -11.3% | 13,390 | -2.3% | 0.02% | -15.8% |
Q1 2019 | $1,724,000 | +2398.6% | 13,710 | +2625.6% | 0.02% | +1800.0% |
Q4 2018 | $69,000 | -50.0% | 503 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $138,000 | +32.7% | 503 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $104,000 | +25.3% | 503 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $83,000 | +20.3% | 503 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $69,000 | +1.5% | 503 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $68,000 | +11.5% | 503 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $61,000 | +15.1% | 503 | 0.0% | 0.00% | – |
Q1 2017 | $53,000 | +5200.0% | 503 | +16666.7% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 3 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 3 | +50.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 2 | -60.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 5 | +150.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |